Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study

Simple item page
dc.contributor.authorOzgun, MA
dc.contributor.authorDogan, I
dc.contributor.authorEryilmaz, MK
dc.contributor.authorErdogan, AP
dc.contributor.authorAyhan, M
dc.contributor.authorHafizoglu, E
dc.contributor.authorTolunay, PK
dc.contributor.authorCavdar, E
dc.contributor.authorCevik, GT
dc.contributor.authorDemir, H
dc.contributor.authorDulgar, O
dc.contributor.authorYilmaz, B
dc.contributor.authorCakir, E
dc.contributor.authorGokyer, A
dc.contributor.authorUnal, OU
dc.contributor.authorPerkin, P
dc.contributor.authorSakalar, T
dc.contributor.authorGulmez, A
dc.contributor.authorTasci, ES
dc.contributor.authorLacin, S
dc.date.accessioned2025-04-10T10:37:23Z
dc.date.available2025-04-10T10:37:23Z
dc.identifier.e-issn1569-8041
dc.identifier.issn0923-7534
dc.identifier.urihttp://hdl.handle.net/20.500.14701/42993
dc.language.isoEnglish
dc.titleReal-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study
dc.typeMeeting Abstract

Files

Collections

Web of Science Koleksiyonu